CBD in Skincare and Dermatology: What the Science Shows So Far
CBD shows promise for multiple skin conditions including acne, psoriasis, and eczema through anti-inflammatory, antioxidant, and sebum-regulating properties, but formulation challenges remain.
Quick Facts
What This Study Found
Preclinical and clinical evidence supports CBD's efficacy for acne, psoriasis, atopic and seborrheic dermatitis, and allergic contact dermatitis. CBD also shows promise for pruritus relief, wound healing, hair loss, and certain skin cancers. Effects are mediated through the skin's endocannabinoid system (CB1, CB2, TRPV channels, PPARs).
Key Numbers
Conditions with supporting evidence: acne, psoriasis, atopic dermatitis, seborrheic dermatitis, allergic contact dermatitis, pruritus, wound healing, androgenetic alopecia, certain skin cancers.
How They Did This
Comprehensive narrative review of preclinical and clinical evidence on CBD's topical therapeutic potential in dermatology and cosmetic science.
Why This Research Matters
The skincare market is flooded with CBD products, but most lack rigorous evidence. This review separates what's supported by science from marketing hype.
The Bigger Picture
The skin has its own endocannabinoid system that regulates inflammation, oil production, cell growth, and barrier function. CBD's broad receptor interactions explain its diverse dermatological potential.
What This Study Doesn't Tell Us
Narrative review. Much evidence is preclinical. CBD's stability and skin penetration pose formulation challenges. Regulatory frameworks vary widely.
Questions This Raises
- ?Which CBD formulations best penetrate the skin?
- ?Are over-the-counter CBD products at therapeutic concentrations?
- ?How does topical CBD compare to established treatments?
Trust & Context
- Key Stat:
- Evidence for CBD across 9+ skin conditions
- Evidence Grade:
- Moderate: comprehensive review with extensive preclinical evidence, but much not yet validated in human trials.
- Study Age:
- Published in 2025.
- Original Title:
- Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science.
- Published In:
- Biomolecules, 15(9) (2025)
- Database ID:
- RTHC-07537
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does CBD actually help with skin conditions?
Preclinical and some clinical evidence supports CBD for acne, psoriasis, eczema, pruritus, and wound healing. CBD interacts with the skin's endocannabinoid system to reduce inflammation and regulate oil production.
Are CBD skincare products worth using?
The science supports CBD's potential, but over-the-counter products vary widely in concentration and quality. Whether a specific product delivers therapeutic CBD levels is often unclear.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07537APA
Rusu, Aura; Farcaș, Andreea-Maria; Oancea, Octavia-Laura; Tanase, Corneliu. (2025). Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science.. Biomolecules, 15(9). https://doi.org/10.3390/biom15091219
MLA
Rusu, Aura, et al. "Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science.." Biomolecules, 2025. https://doi.org/10.3390/biom15091219
RethinkTHC
RethinkTHC Research Database. "Cannabidiol in Skin Health: A Comprehensive Review of Topica..." RTHC-07537. Retrieved from https://rethinkthc.com/research/rusu-2025-cannabidiol-in-skin-health
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.